Nowadays, it’s uncommon to listen to of a startup based in 2019, or one not targeted on AI brokers, elevating a hefty Sequence C. However medical insurance startup Angle Well being introduced Friday that it raised a $200 million Sequence C, alongside a $400 million tender supply, at a $2.7 billion valuation. The spherical was led by Vitruvian Companions with participation from City Corridor Ventures, Blumberg Capital, Portage Ventures, PruVen Capital, and Y Combinator. The tender supply permits staff to money out a few of their shares, the corporate advised TechCrunch. It expects the spherical to shut later this month.
Angle Well being, a winter 2020 YC alum, helps small companies receive and handle what’s often known as “stage funded well being plans.” These are plans that land between absolutely insured and self-funded plans. In absolutely insured plans, the provider takes all of the dangers; such plans are costlier however prices are predictable. With self-funded plans, the corporate covers the bills and prices may be unpredictable. With level-funded plans, companies make predictable funds to carriers, are insured towards higher-than-expected prices, and might doubtlessly lower your expenses by getting a share of the excess again if bills keep low.
Angle says these plans could make medical insurance extra reasonably priced for small companies. It’s an AI-powered platform that helps small companies select and handle plans, integrating with payroll and HR techniques. The startup says it serves over 5,000 companies and is worthwhile.